Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multiple Sclerosis and CCSVI: A Population-Based Case Control Study.
[New and emerging treatments for multiple sclerosis].
Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints.
Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.
CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review.
Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice.
High cumulative JC virus seroconversion rate during long-term use of natalizumab.
Neuroimmunological diseases and pregnancy.
[Uveitis in multiple sclerosis : Overview and perspectives.]
Effect of acetazolamide for long-lasting paroxysmal dystonia in a patient with multiple sclerosis: a case report and review of literature.
Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressure.
Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
Drug expenditure of high-cost patients and their characteristics in Finland.
Serum levels of LIGHT in MS.
Oligodendrocyte-Specific Activation of PERK Signaling Protects Mice against Experimental Autoimmune Encephalomyelitis.
Tremor in multiple sclerosis: The intriguing role of the cerebellum.
Outcomes after Percutaneous Surgery for Patients with Multiple Sclerosis Related Trigeminal Neuralgia.
The endocannabinoid system: a putative role in neurodegenerative diseases.
Expectations of multiple sclerosis patients and their families: a qualitative study in iran.
Perspectives on Physical Activity Among People with Multiple Sclerosis Who Are Wheelchair Users: Informing the Design of Future Interventions.
The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation.
A salty taste to autoimmunity.
Riboflavin Supplementation to Patients with Multiple Sclerosis does not Improve Disability Status nor is Riboflavin Supplementation Correlated to Homocysteine.

Pages